As Chief Executive Officer, Jim leads EVERSANA’s vision to accelerate the industry’s shift to patient-centered, value-based care – creating a healthier world for all. Lang brings more than 30 years of senior leadership experience in leading, advising and funding mission-driven health care companies. Lang previously served as CEO for several large organizations, and also spent nearly two decades building a premier strategy consultant firm. He has been named to the PharmaVOICE 100 list in both 2020 and 2021, and was awarded a PharmaVOICE Red Jacket in 2022. Lang holds a Master of Business Administration from Dartmouth University, and is an executive advisor with Water Street Healthcare Partners.
Greg is President and Chief Revenue Officer at EVERSANA. He is responsible for accelerating the company’s growth and ensuring the success of all client commercialization efforts. With more than 25 years of executive leadership, Greg understands all facets of the pharmaceutical industry, spanning clinical operations to commercial success. Greg’s previous roles include Chief Enterprise Business Officer and Executive Vice President and General Manager at a global bio-pharmaceutical solutions organization, where he successfully managed business units and teams of several thousand employees. Skalicky holds a Bachelor of Science in Biology from Temple University and a Master of Business Administration from Villanova University. He is an active member across several industry panels and consortiums.
Sy is responsible for driving operational excellence across the company’s growing outsourced service solutions and critical infrastructure operations teams. His experience includes more than 25 years in senior leadership roles across the life sciences industry. Most recently he was President, Clinical Development and Chief Medical Officer at Parexel, overseeing more than 16,000 employees worldwide. An honorary Fellow of the Faculty of Pharmaceutical Medicine (FFPM) in the United Kingdom and lecturer in drug development at several institutions including Harvard Medical School, Sy is a Medical Doctor (M.B., Ch.B.) with master’s degrees in Clinical Pharmacology (M.Med.Sc.), Business Administration (MBA) and the Management of Drug Development (MS) from the University of Southern California. He was named to the prestigious PharmaVOICE 100 list in 2017.
As EVERSANA’s Chief Financial Officer (CFO), Kelly Baker directs the company’s financial excellence and leads the platform’s investment and growth strategies. With more than 15 years of financial leadership experience in the healthcare sector, Kelly is a highly regarded financial leader with extensive experience in high-growth organizations, leading mergers and acquisitions. Kelly is a graduate of Union College and earned a Master’s Degree from New York University.
Faruk is EVERSANA’s Chief Innovation Officer and the Chief Executive Officer of EVERSANA INTOUCH, the best-in-class full-service marketing and creative agency of more than 1,800 employees globally that joined EVERSANA in December 2021. Faruk leads the agency team to drive next-generation ideas and strategies for clients across the pharmaceutical and life science industries. He is a graduate of Marmara University and holds a Master of Business Administration from the University of Central Missouri.
Scott serves as EVERSANA’s Chief Digital Officer, driving digital transformation for employees, clients, and the patients we serve. He brings more than 30 years of experience in emerging technologies and digital transformation across both global 1000 companies and startup ventures. Scott is the co-author of Goliath’s Revenge, a book focused on how established companies can turn the table through digital disruption. Scott earned his B.S., M.S., and Ph.D. in Systems Engineering from the University of Pennsylvania.
Maria leads EVERSANA’s Patient Services team, providing strategic and executive oversight to ensure the best possible patient and customer experiences. She brings more than 20 years of experience across operational excellence and strategic development in the pharmaceutical industry. Prior to joining EVERSANA, she led large-scale patient services programs at multiple leading pharmaceutical companies. Maria is a graduate of the Catholic University of America and earned a Master’s Degree from Columbia University.
With more than 25 years of experience in the pharmaceutical industry, Krista leads EVERSANA’s Deployment Solutions service line. Propelled with power of data, analytics and digital technology, Krista is transforming the strategy, activation and impact of field-based commercial, medical and market access teams to drive stronger program performance for therapies worldwide. Recently recognized as a MM&M Hall of Femme Honoree and a two-time Rising Star by the Healthcare Businesswoman’s Association, Krista holds a Bachelor’s Degree from the University of Delaware.
Danny leads EVERSANA’s Channel Management service line. He brings more than 20 years of experience leading teams to excel in commercial aspects of the pharmaceutical and services industries. His team helps to efficiently deliver therapies to patients, ensure regulatory compliance, and support medical information and pharmacovigilance. Danny is a graduate of the University of Mississippi, and holds a Master of Business Administration from Mississippi College.
Vikram leads EVERSANA’s Compliance Service service line. His experiences include more than 20 years of leading global teams and building successful partnerships with top life sciences companies and health authorities around the globe. His team includes Medical Communications, Pharmacovigilance, Product and Medical Information Contact Center, and Regulatory & Quality Consulting/Outsourcing Services. He holds a Bachelor in Science Degree in Pharmacy from Punjabi University, a Master of Business Administration from Manipal University, and Post Graduate Diploma in Digital Strategies & Transformation from Columbia Business School/MIT Sloan.
Faruk leads EVERSANA’s Professional Services Division including multiple advisory teams as well as the value & evidence service line. He is responsible for driving growth and accelerating go-to-market efforts for EVERSANA. His career spans more than 20 years in corporate strategy and business development, customer engagement, entrepreneurship and technology. Most recently in EVERSANA, he led the growth and expansion of the EVERSANA CONSULTING team across the North American and European regions. Prior to joining EVERSANA, he was a senior leader at various consulting firms and technology companies, helping contribute to the successful development and launch of products across therapeutic and medical device categories. He holds a Bachelor’s Degree in Electrical Engineering from Northwestern University and a Master of Business Administration from Harvard Business School.
Alan drives the US and Global products portfolio at EVERSANA, an industry-leading portfolio of products covering brand, account and market access insights, global pricing and market access data, and global pricing, contracting, market access, contracting and revenue software. Alan leads this team in helping EVERSANA address clients’ global product lifecycle and price and access needs. With more than 20 years in the life sciences industry, his experience includes spearheading innovative software, data and solutions for global pricing and access, global data collection and analysis, and leveraging advanced algorithms to support commercial decisions. He has shared his expertise globally at industry conferences and has led numerous large-scale technology projects throughout his career. Alan worked previously as a vice president at CapGemini and at Accenture. Alan is a graduate of Princeton University.
Jim Burke leads the Revenue Management team with more than 20 years of experience optimizing gross-to-net operations for the pharmaceutical and medical device industries. An established thought leader in life sciences, he drives the implementation of best practices and innovative solutions that help companies optimize their investment in access and affordability programs through a combination of process efficiencies and holistic life cycle analytics. His team leads the way in creating first-to-market software programs that eliminate revenue leakage through unique automated transaction validation algorithms and master data alignment. Jim is an alumnus of the Stevens Institute of Technology.
Mike leads EVERSANA’s operations in Europe, the Middle East and Africa, and is responsible for accelerating growth throughout the region. He brings more than 25 years of experience to the industry, having held, global leadership positions in both clinical development and life sciences software companies. Ryan passionately believes that technology can simplify the development of novel therapies and improve access to treatment. He holds a degree in Industrial Biochemistry from University Limerick and earned his Master of Business Administration from the University College Cork.
As Executive Vice President of EVERSANA’s Asia Pacific region, Rob, together with Ravi Visweswara, is responsible for accelerating growth throughout the region. With more than 30 years of consulting and leadership experiences at global pharmaceutical companies across three continents, Arnold’s focus is on accelerating the company’s growth in the region. He holds both a Bachelor of Arts and Master of Law from University of Cambridge, as well as a Master of Business Administration from the Tuck School of Business at Dartmouth.
Ravi is Executive Vice President of EVERSANA’s Asia Pacific region, and together with Rob Arnold, is responsible for accelerating the company’s growth in the region. Visweswara brings more than 20 years of consulting and executive leadership experiences to EVERSANA, including previous roles leading the growth of international brands in the Asia Pacific region. He holds a Bachelor of Technology degree from Indian Institute of Technology, and earned a Master of Business Administration from the Indian Institute of Management.
Rohit leads the EVERSANA COMPLETE Commercialization® business which consists of a world-class global life sciences commercialization team who drive the execution of our partnered multi-TA portfolio. He is responsible for shaping the commercial structure, operations, and culture that delivers our innovative and disruptive EVERSANA COMPLETE model. During his three decades of strategy and operations experience in the life science and technology services industries, Rohit has advised senior management and CxOs of global life science companies on critical business areas. Rohit has a track record of driving topline business growth while identifying significant operational efficiencies in PE-backed, startup, and publicly listed organizations.
Dr. Russo serves as EVERSANA’s Chief Medical Officer. He is responsible for ensuring the highest levels of quality and data integrity in the design and delivery of projects that require the translation of clinical, population medicine and health economic knowledge into actionable analyses across all programs. A cardiac thoracic and transplant surgeon, he began his career at the Mayo Clinic, and then served in clinical leadership roles at several academic hospitals including Temple University/St Christopher’s Hospital, Philadelphia and the University of Missouri. He holds a Certificate in Health Care Innovation-Health and Health Care Administration Management from the University of Pennsylvania-Philadelphia and a Certificate in Digital Medicine (Node.Health). He is a member of the American Heart Association and has served as a lecturer in population medicine at the Harvard Medical School.
Ryan is the Chief Information Officer of EVERSANA, overseeing the platform’s technology operation, including its global application development, IT infrastructure, security, compliance, and data and analytics. Sparks brings a 25-year track record of delivering business results in complex environments across diverse industries. His cross-functional experiences include technology, data strategy, product management, operations and finance. He is a decorated veteran of the U.S. Marine Corps, where he served for more than 16 years and earned multiple honors, including a Silver Star, the Bronze Star with Combat “V,” and two Purple Hearts. Sparks holds a Bachelor of Arts Degree in Political Science from the University of Kansas, a Master of Science Degree in Global Leadership from the University of San Diego, and a Master of Business Administration from New York University.
Fred is the Chief People Officer at EVERSANA and leads the company’s effort to build a thriving culture and earn recognition as a best place to work. With nearly 15 years of experience in the HR industry, Skinner brings a wide array of experience across employee engagement and talent acquisition functions from multiple industries, including consulting, healthcare, software development, diversified manufacturing and automotive. He holds a Master’s Degree from Roosevelt University.
Franco is EVERSANA’s General Counsel and Chief Compliance Officer, and is responsible for all legal matters for the organization. He brings more than 15 years of legal and compliance industry experience across multiple industries to the team, and provides strategic counsel to the CEO and senior management team on legal matters. He holds a Juris Doctor degree from Northern Illinois University College of Law.
Sarah leads the company’s marketing, public relations and employee communications as Chief Marketing & Corporate Communications Officer. Her team helps increase awareness of EVERSANA’s value to all stakeholders. Sarah has more than 20 years of integrated communications experience within public and private companies, including the healthcare, energy, government, media and agency sectors. She holds a Bachelor’s Degree from the University of Wisconsin.
Brigham serves as a special advisor to EVERSANA. He provides insights on strategy, growth and partnership opportunities. His experiences include more than two decades of work in data science and artificial intelligence (AI) and he excels at building the best-in-class data software technologies to empower executives to make informed choices. He is a member of Forbes Technology Council, an exclusive group of senior-level technology executives who discuss how emerging technologies can change the way we live. Brigham is also an adjunct professor in pharmacology and experimental therapeutics at Tufts University and serves on the research faculty at MIT Media Lab. He holds a bachelor’s degree in chemistry from Northeastern University and a PhD in Pharmacology and Experimental Therapeutics from Tufts University School of Medicine.